Self-help metacognitive therapy – which aims to reduce rumination – significantly reduces anxiety and depression symptoms in recovering heart disease patients, according to new randomized controlled trial
Credit: Hassan OUAJBIR, Pexels (CC0, https://creativecommons.org/publicdomain/zero/1.0/)
Self-help metacognitive therapy – which aims to reduce rumination – significantly reduces anxiety and depression symptoms in recovering heart disease patients, according to new randomized controlled trial
In your coverage, please use this URL to provide access to the freely available paper in PLOS Medicine: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004161
Article Title: Metacognitive therapy home-based self-help for anxiety and depression in cardiovascular disease patients in the UK: A single-blind randomised controlled trial
Author Countries: United KingdomFunding: This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research (PGfAR) Programme (Grant Reference Number RP-PG-1211-20011). AW was awarded the grant. https://fundingawards.nihr.ac.uk/award/RP-PG-1211-20011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Journal
PLoS Medicine
DOI
10.1371/journal.pmed.1004161
Method of Research
Randomized controlled/clinical trial
Subject of Research
People
COI Statement
Competing interests: The authors have declared that no competing interests exist.
